Bank of America
KERX

Bank of America’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bank of America’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-125,000
Closed -$1.59M – 7533
2015
Q1 		$1.59M Buy
125,000
+120,100
+2,451% +$1.54M ﹤0.01% 3434
2014
Q4 		$69K Sell
4,900
-17,900
-79% -$277K ﹤0.01% 6150
2014
Q3 		$314K Buy
22,800
+18,400
+418% +$282K ﹤0.01% 4990
2014
Q2 		$68K Sell
4,400
-9,100
-67% -$129K ﹤0.01% 6424
2014
Q1 		$230K Sell
13,500
-20,100
-60% -$303K ﹤0.01% 5311
2013
Q4 		$435K Buy
33,600
+17,800
+113% +$213K ﹤0.01% 4880
2013
Q3 		$159K Buy
15,800
+6,800
+76% +$60.5K ﹤0.01% 5643
2013
Q2 		$67K Buy
+9,000
New +$70.3K ﹤0.01% 6390

Bank of America's KERX Position: Q4 2018 in Review

Bank of America sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 163,226 shares — an estimated $555K sold.

Bank of America first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $4.13M in Q3 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Bank of America reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Bank of America sold 163,226 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $555K.
  • Bank of America first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
  • Bank of America's Keryx Biopharmaceuticals Inc position peaked at $4.13M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Bank of America's 13F filing for Q4 2018, filed 14 Feb 2019.